ATE440103T1 - Mannose-6-phosphonat-verbindungen zur behandlung von entzündungskrankheiten - Google Patents
Mannose-6-phosphonat-verbindungen zur behandlung von entzündungskrankheitenInfo
- Publication number
- ATE440103T1 ATE440103T1 AT04752819T AT04752819T ATE440103T1 AT E440103 T1 ATE440103 T1 AT E440103T1 AT 04752819 T AT04752819 T AT 04752819T AT 04752819 T AT04752819 T AT 04752819T AT E440103 T1 ATE440103 T1 AT E440103T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- mannose
- treatment
- migration
- inflammatory diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
- C07H11/04—Phosphates; Phosphites; Polyphosphates
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47171603P | 2003-05-20 | 2003-05-20 | |
| PCT/US2004/015876 WO2004104015A2 (en) | 2003-05-20 | 2004-05-20 | Mannose-6-phosphonate compounds for the treatment of inflammatory diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE440103T1 true ATE440103T1 (de) | 2009-09-15 |
Family
ID=33476877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04752819T ATE440103T1 (de) | 2003-05-20 | 2004-05-20 | Mannose-6-phosphonat-verbindungen zur behandlung von entzündungskrankheiten |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7648966B2 (de) |
| EP (1) | EP1628987B1 (de) |
| AT (1) | ATE440103T1 (de) |
| AU (1) | AU2004240938B2 (de) |
| CA (1) | CA2525328C (de) |
| DE (1) | DE602004022659D1 (de) |
| DK (1) | DK1628987T3 (de) |
| ES (1) | ES2330004T3 (de) |
| NZ (1) | NZ544085A (de) |
| PL (1) | PL1628987T3 (de) |
| PT (1) | PT1628987E (de) |
| WO (1) | WO2004104015A2 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2930942B1 (fr) * | 2008-05-07 | 2011-03-04 | Centre Nat Rech Scient | Nouvelles utilisations de derives de d-mannopyranose activateurs de l'angiogenese |
| JP2012525369A (ja) * | 2009-04-28 | 2012-10-22 | ファーマキシス リミテッド | 創傷および線維性障害の治療のためのホスホテトラヒドロピラン化合物 |
| SG11202106209RA (en) | 2018-12-19 | 2021-07-29 | Univ Leland Stanford Junior | Bifunctional molecules for lysosomal targeting and related compositions and methods |
| KR20240036604A (ko) | 2021-07-14 | 2024-03-20 | 리시아 테라퓨틱스, 인크. | Asgpr 세포 표면 수용체 결합 화합물 및 접합체 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61502124A (ja) * | 1984-05-09 | 1986-09-25 | ジ オ−ストラリアン ナシヨナル ユニヴア−シテイ− | 免疫応答の調節方法 |
| US6140301A (en) * | 1995-04-27 | 2000-10-31 | The Procter & Gamble Company | Process for producing granular detergent components or compositions |
| GB9516012D0 (en) * | 1995-08-04 | 1995-10-04 | Univ Manchester | Pharmaceutical composition |
| AU728393B2 (en) * | 1996-10-18 | 2001-01-11 | Australian National University, The | Novel phosphosugars and phosphosugar-containing compounds having anti-inflammatory activity |
| AUPQ872300A0 (en) * | 2000-07-11 | 2000-08-03 | Praxis Pharmaceuticals Pty Ltd | Compounds and methods |
-
2004
- 2004-05-20 AT AT04752819T patent/ATE440103T1/de active
- 2004-05-20 US US10/557,773 patent/US7648966B2/en not_active Expired - Fee Related
- 2004-05-20 ES ES04752819T patent/ES2330004T3/es not_active Expired - Lifetime
- 2004-05-20 AU AU2004240938A patent/AU2004240938B2/en not_active Ceased
- 2004-05-20 CA CA2525328A patent/CA2525328C/en not_active Expired - Fee Related
- 2004-05-20 EP EP04752819A patent/EP1628987B1/de not_active Expired - Lifetime
- 2004-05-20 DE DE602004022659T patent/DE602004022659D1/de not_active Expired - Lifetime
- 2004-05-20 PL PL04752819T patent/PL1628987T3/pl unknown
- 2004-05-20 NZ NZ544085A patent/NZ544085A/en not_active IP Right Cessation
- 2004-05-20 PT PT04752819T patent/PT1628987E/pt unknown
- 2004-05-20 DK DK04752819T patent/DK1628987T3/da active
- 2004-05-20 WO PCT/US2004/015876 patent/WO2004104015A2/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004240938B2 (en) | 2009-11-19 |
| WO2004104015A3 (en) | 2005-03-24 |
| US7648966B2 (en) | 2010-01-19 |
| ES2330004T3 (es) | 2009-12-03 |
| WO2004104015A8 (en) | 2005-05-26 |
| DK1628987T3 (da) | 2009-12-21 |
| US20070082850A1 (en) | 2007-04-12 |
| NZ544085A (en) | 2008-10-31 |
| EP1628987A2 (de) | 2006-03-01 |
| WO2004104015A2 (en) | 2004-12-02 |
| DE602004022659D1 (de) | 2009-10-01 |
| EP1628987B1 (de) | 2009-08-19 |
| PL1628987T3 (pl) | 2010-01-29 |
| AU2004240938A1 (en) | 2004-12-02 |
| PT1628987E (pt) | 2009-10-29 |
| CA2525328C (en) | 2012-07-31 |
| CA2525328A1 (en) | 2004-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Krystal et al. | SHIPs ahoy | |
| EA200602191A1 (ru) | 5,5-дизамещённые-2-амино-4-тиазолидиноны и способ их получения, фармацевтическая композиция и способ лечения | |
| BR9812111A (pt) | Dipeptìdeo e compostos correlatos que inibem adesão de leucócito mediada por vla-4 | |
| BR9811599A (pt) | Compostos de dipetìdeo que inibem adesão de leucócito mediada por vla-4 | |
| DE60224879D1 (de) | Verwendung von dpiv-inhibitoren als therapeutika für krankhafte neurologische zustände | |
| ATE544748T1 (de) | Zusammensetzungen und verfahren für die behandlung von zellproliferationserkrankungen | |
| MA27675A1 (fr) | Derives de piperazine et leur utilisation dans le traitement de maladies neurologiques et psychiatriques | |
| ATE203159T1 (de) | Verbindungen zur behandlung von allergischen und entzündlichen erkrankungen | |
| BRPI0410454A (pt) | composições e compostos imunossupressores | |
| MA28241A1 (fr) | Derives d'indole hydroxyethylamine tricycliques et leur utilisation dans le traitement de la maladie d'alzheimer | |
| ATE396973T1 (de) | Benzylether- und benzylamino-beta-sekretase- hemmer zur behandlung von alzheimer-krankheit | |
| EA200601239A1 (ru) | Замещённые хинолиновые соединения | |
| EA200501710A1 (ru) | Замещённые карбоновые кислоты | |
| ATE460413T1 (de) | Substituierte 1-propinoyl-piperazine mit affinität für den mglur5 rezeptor zur behandlung von schmerzzuständen | |
| NO20052272L (no) | CCR1-antagonister for behandling av blant annet demylinerene inflamasjonssykdom | |
| ATE339205T1 (de) | (3-ä3-'(2,4-bis-trifluormethyl-benzyl)-(5-ethyl pyrimidin-2-yl)-amino)-propoxyü-phenyl)- essigsäure und verwandte verbindungen als modulatoren von ppars und verfahren zur behandlung von stoffwechselstörungen | |
| ATE260653T1 (de) | Verwendung von naaladase inhibitoren zur behandlung von angstzuständen und gedächtnisstörungen | |
| EA200100342A1 (ru) | Связывающие соединения адгезионной молекулы нервной клетки | |
| ATE440103T1 (de) | Mannose-6-phosphonat-verbindungen zur behandlung von entzündungskrankheiten | |
| ATE538796T1 (de) | Piperidin- und pyrrolidin-beta-secretase-hemmer zur behandlung von alzheimer-krankheit | |
| ATE290857T1 (de) | Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen | |
| MX2007000046A (es) | Compuestos, composiciones y metodos de imidazolo relacionados para su uso. | |
| ATE313561T1 (de) | Vgf polypeptide und verfahren zur behandlung von vgf-erkrankungen | |
| EA200601607A1 (ru) | Сульфонамидные соединения для лечения нейродегенеративных расстройств | |
| ATE435649T1 (de) | 4-brom-5-(2-chlor-benzoylamino)-1h-pyrazol-3- carbonsäure(phenyl)amid-derivate und verwandte verbindungen als bradykinin b1 receptor antagonisten zur behandlung von entzündlichen erkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1628987 Country of ref document: EP |